Clinical Trial Update: Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand Eczema [Phase 2]

View source ↗

Summary

Phase 2 trial investigating ASN002 for moderate to severe chronic hand eczema has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Dermatitis

Drugs mentioned

• ASN002

Snippet

Sponsor: Asana BioSciences | Conditions: Chronic Hand Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-05-09